Studies have shown that elevated levels of VEGF-A are associated with poor prognosis in various cancers; for example, in breast cancer and lung cancer patients, high expression of VEGF-A is closely related to tumor aggressiveness and metastasis (Banerjee et al., 2023; Liao et al., 2022). This evidence concerns the gene VEGFA and breast cancer.